Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 4Withdrawn 1Terminated 1Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Myeloid 1Lymphoid 1

Conditions

Multiple Myeloma 43Precursor Cell Lymphoblastic Leukemia-Lymphoma 14Recurrence 7Lymphoma, Non-Hodgkin 6Burkitt Lymphoma 6Neoplasms, Plasma Cell 5Nausea 5Leukemia 5Vomiting 4Prostatic Neoplasms 4Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 4Neoplasms 4Lymphoma 4Neoplasm Metastasis 3Lymphoma, Large B-Cell, Diffuse 3Hematologic Neoplasms 3Amyloidosis 3Smoldering Multiple Myeloma 2Oligodendroglioma 2Lung Neoplasms 2Leukemia, Myeloid, Acute 2Leukemia, Biphenotypic, Acute 2Immunoglobulin Light-chain Amyloidosis 2Carcinoma, Non-Small-Cell Lung 2Breast Neoplasms 2Astrocytoma 2Waldenstrom Macroglobulinemia 1Uveal Melanoma 1Squamous Cell Carcinoma of Head and Neck 1Spinal Cord Neoplasms 1

Interventions

Cyclophosphamide 10fludarabine phosphate 9Peripheral Blood Stem Cell Transplantation 8Busulfan 8Antilymphocyte Serum 8Mycophenolic Acid 7Whole-Body Irradiation 6Tacrolimus 6Methylprednisolone 6Methotrexate 6Cyclosporine 6Radiotherapy 5Filgrastim 5Cord Blood Stem Cell Transplantation 5Sirolimus 4Rituximab 4Flow Cytometry 4Cytarabine 4Thiotepa 3Melphalan 3Imatinib Mesylate 3Granulocyte Colony-Stimulating Factor 3Etoposide 3Dasatinib 3venetoclax 2ponatinib 2aldesleukin 2Tretinoin 2Therapeutics 2Sunitinib 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × Blast Crisis × Calcium Dobesilate × Clear all
NCT03576547 2025-05-08

Venetoclax, Ponatinib, and Dexamethasone in Participants With Philadelphia Chromosome or BCR-ABL Positive Relapsed or Refractory Acute Lymphoblastic Leukemia or Chronic Myelogenous Leukemia

M.D. Anderson Cancer Center

Phase 1/2 Terminated
9 enrolled 11 charts
LymphoidMyeloidOther hematologic neoplasm

Blast Crisis, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡